Avinger, Inc. (NASDAQ:AVGR) headquartered in Redwood City, will host a conference call for the investment community to discuss the 3Q20 financial results on 10th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.avinger.com
Earnings Expectation
Avinger, Inc. manufacturer of medical devices and components, is reporting third quarter earnings results on Tuesday 10th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.1 per share from $ 1.98 million in revenue. For the full year, analysts predict revenues of $ 8.04 million, while looking forward to loss of $ 0.69 per share.
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The companys lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.
